Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03203525
Title Study of the NovoTTF-100L System to Enhance Antitumor Activity in Patients With Predominant Hepatic Metastatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

colorectal cancer

Advanced Solid Tumor

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Doxorubicin + Temsirolimus

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.